How a Life Sciences Media Agency Won a $200K Project with a Clinical-Stage Biopharmaceutical Company
| Client Type | Life Sciences Media Planning and Analytics Agency |
| Win | $200K Initial Project, Clinical-Stage Biopharmaceutical Company |
| Verticals Served | Pharmaceuticals, Biotechnology, Rare Disease, Life Sciences, Healthcare |
The Challenge: Deep Life Sciences Expertise With No Consistent Path to New Pharma and Biotech Clients
This media planning and analytics agency worked exclusively in the life sciences space.
They understood the regulatory environment that shapes what can and can’t be said in promotional materials, the complexity of reaching both healthcare providers and patients with distinct messages through distinct channels, and how to build media plans that could demonstrate ROI in an industry where measurement is hard and scrutiny is high.
Their planning suite, which combined AI and machine learning with deep pharma marketing expertise, gave them a concrete differentiator in a space where data-driven decision-making around promotional investment was increasingly expected by brand teams and senior leadership alike.
For clinical-stage companies moving toward commercialization, having a media and analytics partner who could operate at that level of rigor mattered.
The challenge was getting that story in front of the right marketing and commercial decision-makers at pharma and biotech companies consistently enough to build a reliable pipeline.
Why Outsourced New Business Made Sense
Pharmaceutical and biotech companies choose marketing partners with caution. Because the decision requires input from brand, commercial, medical, and regulatory teams, the process can be lengthy.
For clinical-stage companies building out their commercial infrastructure, the timing of those conversations is often tied to pipeline milestones and approval timelines, which makes staying visible with the right contacts over time especially important.
RSW/US assigned a dedicated New Business Director to work on the agency’s behalf, reaching marketing, brand, and commercial decision-makers at pharmaceutical and biotech companies through the RSDW tech stack phone, email, LinkedIn, and direct mail.
The messaging spoke directly to the challenges those teams face in building data-driven media programs that hold up under internal scrutiny and deliver measurable impact in a regulated promotional environment.
How RSW/US Built the Program
The kick-off focused on making the agency’s life sciences-only positioning concrete and compelling and their planning suite gave RSW/US a specific, tangible capability to bring to market: a proprietary planning platform that integrates AI and ML to optimize promotional budget and give leadership teams evidence-based rationale for every investment decision.
RSW/US built a targeted prospect list of pharmaceutical companies, biotech firms, and rare disease organizations where the agency’s omnichannel media capabilities and analytics tools were directly relevant.
Outreach was designed to speak to the pressures those commercial teams face in communicating complex science to HCPs and patients in a way that is both compliant and moves behavior.
The Result: A $200K Initial Project with a Clinical-Stage Biopharmaceutical Company
The agency won a $200K initial project with InflaRx, a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system, with programs in rare inflammatory diseases including hidradenitis suppurativa and pyoderma gangrenosum.
For a life sciences media agency whose practice was built specifically around helping pharma and biotech companies reach HCPs and patients with precision and accountability, it was a direct result of consistent outreach that put the right capabilities in front of the right client.
Learn more about InflaRx.
Is Your Agency Getting in Front of the Pharma and Biotech Companies That Need What You Do?
Pharmaceutical and biotech companies are active buyers of media and marketing services, especially as they build commercial infrastructure around pipeline milestones.
RSW/US can help you get in front of the right decision-makers before they start a formal search. We build the program, generate the right meetings, and help move opportunities forward.
Want to see exactly what’s included in a full program? Explore Our Offerings
